Presentation TCT 2016 TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry Presenter: Germano Di Sciascio, Bruno Scheller November 01, 2016
Presentation TCT 2016 Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella November 01, 2016
Presentation TCT 2016 Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry Presenter: Fernando Alfonso, Ran Kornowski, Bernardo Cortese November 01, 2016
Presentation TCT 2016 Case Resolution: How Did We Treat this Patient? Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TAVR Restenosis: Review of the Literature Presenter: Nick Curzen October 31, 2016
Presentation TCT 2016 Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR Presenter: Nick Curzen, Michael Mahmoudi October 31, 2016
Presentation TCT 2016 TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo October 31, 2016
Presentation TCT 2016 TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades Presenter: Stephan Baldus, Allan Schwartz, Alfredo Nunes Ferreira Neto October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016
Presentation TCT 2016 How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini October 30, 2016
Presentation TCT 2016 Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns October 30, 2016
Presentation TCT 2016 Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi October 30, 2016
Presentation TCT 2016 OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee October 30, 2016
Presentation TCT 2016 Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis? Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz October 30, 2016
Presentation TCT 2016 New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples) Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara October 30, 2016
Presentation TCT 2016 Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda October 30, 2016
Presentation TCT 2016 Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES? Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman October 30, 2016